Invitation to the presentation of BICO’s Interim report Q3 2025
October 21, 2025 7:00 amBICO’s Interim report Q3 2025 will be published on Tuesday November 4, 2025, at 07:00am CET. Following the release of the report, a telephone conference with the opportunity to ask questions will be held in English at 10:00 am CET on the same day, with President & CEO Maria Forss and CFO Jacob Thordenberg presenting the Interim report.
Information about the presentation and webcast
The presentation will be available on BICO’s website from 09:00am CET.
https://bico.com/investors/
If you wish to participate via webcast, please use the link below: https://bico.events.inderes.com/q3-report-2025
If you wish to participate via teleconference, please register via the link below. After registration you will be provided with phone numbers and a conference ID to access the conference. You can ask questions verbally via teleconference.
https://conference.financialhearings.com/teleconference/?id=5006911
For further information, please contact:
Jacob Thordenberg, CFO, BICO Group AB
Phone: +46 735 34 88 84
E-mail: jt@bico.com
The information was submitted for publication, through the agency of the contact person set out above, on October 21, 2025 at 7am CEST.
About BICO
BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 10,900 publications. Operating through two business areas – Lab Automation and Life Science Solutions – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com